# LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer

> **NCT02164942** · — · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 6 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02164942
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-06
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Futility
- **Last updated:** 2022-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02164942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02164942, "LCI-GU-BLA-SPEC-001: Aurora Kinase Expression in Muscle-Invasive Bladder Cancer". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT02164942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*